These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 3495325

  • 1. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
    Umezawa H, Nishikawa K, Shibasaki C, Takahashi K, Nakamura T, Takeuchi T.
    Cancer Res; 1987 Jun 15; 47(12):3062-5. PubMed ID: 3495325
    [Abstract] [Full Text] [Related]

  • 2. [Spergualin, a new antitumor antibiotic].
    Takeuchi T.
    Gan To Kagaku Ryoho; 1987 Mar 15; 14(3 Pt 2):845-9. PubMed ID: 3566295
    [Abstract] [Full Text] [Related]

  • 3. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM, Kawashima K, Nakashima I, Nagase F.
    Cancer Res; 1988 Nov 15; 48(22):6450-4. PubMed ID: 3263189
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov 15; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of spergualin, a novel antitumor antibiotic.
    Nishikawa K, Shibasaki C, Takahashi K, Nakamura T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Oct 15; 39(10):1461-6. PubMed ID: 3781914
    [Abstract] [Full Text] [Related]

  • 6. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.
    Kataoka T, Oh-hashi F.
    Cancer Res; 1985 Jul 15; 45(7):2962-6. PubMed ID: 3873988
    [Abstract] [Full Text] [Related]

  • 7. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
    Bowlin TL, Prakash NJ, Edwards ML, Sjoerdsma A.
    Cancer Res; 1991 Jan 01; 51(1):62-6. PubMed ID: 1988107
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH, Wallace TL, Richard KA, Tracey DE.
    Cancer Res; 1985 Feb 01; 45(2):532-8. PubMed ID: 3967227
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Spergualin: a new antitumour antibiotic.
    Umezawa K, Takeuchi T.
    Biomed Pharmacother; 1987 Feb 01; 41(5):227-32. PubMed ID: 3499181
    [Abstract] [Full Text] [Related]

  • 11. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
    Miura T, Maekawa T, Kurashige S, Mitsuhashi S.
    Cancer Res; 1981 Feb 01; 41(2):383-98. PubMed ID: 6160907
    [Abstract] [Full Text] [Related]

  • 12. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T.
    Jpn J Exp Med; 1987 Apr 01; 57(2):103-15. PubMed ID: 3499533
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y, Saito M, Fukushima H, Takeda Y, Hara T.
    Cancer Res; 1984 Jan 01; 44(1):25-30. PubMed ID: 6197162
    [Abstract] [Full Text] [Related]

  • 17. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M, Orosz CG, Bach FH.
    J Immunol; 1984 Jun 01; 132(6):3218-25. PubMed ID: 6202778
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C, Archetti YL, Aresca P, Del Vecchio L.
    Cancer Res; 1985 Nov 01; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.